21 results
Pain Assessment and Management Initiative (PAMI) - Transdermal Medications

#Management #Pain #Pharmacology #Transdermal #Topical #Medications #Doses #Dosing
Pain Assessment ... Management #Pain ... #Pharmacology # ... Doses #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Non-Opioid Analgesics - Agents and Dosing

#Management #Pain #Pharmacology #NonOpioid
Pain Assessment ... #Pain #Pharmacology ... NonOpioid #Analgesics #Medications ... Doses #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Neuropathic Pain Medications:

Agent, Initiation Dose and Max Dosages

 -
(PAMI) - Neuropathic ... Pain Medications ... #Pain #Pharmacology ... Doses #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Muscle Relaxants - Agents and Dosing

#Management #Pain #Pharmacology #Muscle
Pain Assessment ... #Pain #Pharmacology ... Relaxers #Relaxants #Medications ... Doses #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Nerve Blocks - Nerve Distribution, Agents and Dosing Table
Pain Assessment ... (PAMI) - Nerve ... #Pain #Pharmacology ... Nerve #Blocks #Medications ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Intranasal and Nebulized Medications- Agents and Dosing

#Management #Pain #Pharmacology
Pain Assessment ... (PAMI) - Intranasal ... #Pain #Pharmacology ... Doses #Dosing #Table ... #PAMI
Pain Assessment and Management Initiative (PAMI) - Nonpharmacologic Interventions (pediatric and adult)
Physical (Sensory) Interventions
 - Comfort
Pain Assessment ... - Hot or Cold treatments ... techniques (breathing, meditation ... Interventions #Table ... #PAMI
Managing warfarin INR

Warfarin dosage must be individualized according to the patient's response to the drug, and
#management #algorithm ... #pharmacology # ... treatment #medications ... #table #pharmacotherapy ... #decisionaid #cardiology
IDSA Recommendations for Preventing and Treating Toxoplasma gondii Encephalitis in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
IDSA Recommendations ... for Preventing ... #Prevention #Treatment ... infections #HIVAIDS #management ... pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... chew, or crush tablet ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology